Bitter Pills: Inside the Hazardous World of Legal Drugs

Overview

We take our medicines on faith. We assume our doctors are well-informed, our drug companies scrupulous, our FDA diligent?and our medications safe. All too often we're wrong. Just how wrong is documented in this critically acclaimed portrait of the international pharmaceutical industry by one of our most highly respected investigative journalists.

According to the Journal of the American Medical Association (JAMA), adverse drug reactions are the fourth leading cause of death in ...

See more details below
Other sellers (Paperback)
  • All (29) from $1.99   
  • New (8) from $12.87   
  • Used (21) from $1.99   
Bitter Pills: Inside the Hazardous World of Legal Drugs

Available on NOOK devices and apps  
  • NOOK Devices
  • NOOK HD/HD+ Tablet
  • NOOK
  • NOOK Color
  • NOOK Tablet
  • Tablet/Phone
  • NOOK for Windows 8 Tablet
  • NOOK for iOS
  • NOOK for Android
  • NOOK Kids for iPad
  • PC/Mac
  • NOOK for Windows 8
  • NOOK for PC
  • NOOK for Mac
  • NOOK Study
  • NOOK for Web

Want a NOOK? Explore Now

NOOK Book (eBook)
$13.99
BN.com price

Overview

We take our medicines on faith. We assume our doctors are well-informed, our drug companies scrupulous, our FDA diligent—and our medications safe. All too often we're wrong. Just how wrong is documented in this critically acclaimed portrait of the international pharmaceutical industry by one of our most highly respected investigative journalists.

According to the Journal of the American Medical Association (JAMA), adverse drug reactions are the fourth leading cause of death in America. Reactions to prescription and over-the-counter medications kill far more people annually than all illegal drug use combined.

Stephen Fried's wife took a pill for a minor infection—and ended up in the emergency room. Some drug reactions go away in a few hours or days. Diane's did not. This emotionally wrenching experience launched Fried into a five-year examination of the entire pharmaceutical industry, the most profitable legal business in the world. Rigorously documented, Bitter Pills is a full-scale portrait of pill making and pill taking in America today, presented through the powerful human drama of doctors, patients, drug companies, the FDA, and government regulators as they war for control of our medicine cabinets.

"Written by an award-winning journalist, this investigation of the legal drug culture is a moving personal memoir and a devastating exploration of pharmaceutical companies, drug regulators, doctors, pharmacists, & unsuspecting patients."

Read More Show Less

Editorial Reviews

From the Publisher
"Explosive."—People

" [Bitter Pills] could save your life."—San Diego Union-Tribune

"The best popular book I've read on the subject."—The New York Times Book Review

"Chilling...fascinating...poignant."—Newsday

"If you have concerns about drugs your family members have been prescribed or are taking over the counter, Bitter Pills will help make you a more informed consumer."—Rocky Mountain News

"One of the year's best books...startling...sobering."—Philadelphia Inquirer

"Absorbing...insightful...fascinating and often frightening." —Kirkus Reviews

Journal of the American Medical Association
The book is overall informative and engaging. It serves as an excellent primer and source of information for consumers of medication and professionals alike and is well indexed and readable. I would recommend Bitter Pills to anyone who uses or prescribes pharmaceuticals.
Charles C. Mann
...the best popular book I've read on the subject....More knowledge or more affordable drugs? Such awful dilemmas, common in pharmaceitical circles, should be widely discussed at a time when medical care is of ever-greater public concern. Bitter Pills helps inform the debate.
New York Times Book Review
Publishers Weekly - Publisher's Weekly
Five years ago, Fried's wife, after taking an antibiotic for a minor urinary tract infection, developed such side effects as delirium, visual distortions and insomnia, followed by a debilitating manic-depressive illness that the prescription drug apparently triggered. This report on the often lethal hazards of over-the-counter and prescription medications intertwines Fried's personal story of coping with his wife's condition and an informal, scattershot probe into the drug development and approval process, based on interviews with doctors, FDA officials, consumer advocates, neuroscientists, pharmaceutical executives and sales reps, lawyers and pharmacologists. By turns tedious and revealing, his labyrinthine investigation is sprinkled with useful suggestions for revamping U.S. drug testing and regulatory procedures. Freelance writer Fried includes cases involving adverse reactions to heart medicines, anti-inflammatory and psychiatric drugs, skin creams, anti-asthmatics and AIDS medications. He highlights the laxity of safety standards regarding the prescribing of drugs for children and pregnant women. An appendix offers guidelines for consumers on assessing potential drug dangers, and dealing with doctors and pharmacists.
Booknews
Investigative journalist Stephen Fried explores the sometimes deadly world of legal, mostly prescription, drugs. After his wife became extremely ill using a prescription drug in 1992, Fried launched into an investigation of that specific drug, the drug companies, the FDA, doctors' educations, and the thousands of adverse reactions to legal drugs every year. Several appendices (written with the aid of doctors) educate consumers on how to read a drug package insert, how to make one's doctor write smarter prescriptions, and how to avoid adverse reactions. Annotation c. by Book News, Inc., Portland, Or.
Booknews
This sobering investigation into serious hazards of prescription and over-the-counter (OTC) legal drugs in the US begins with a harrowing account of the author's wife's debilitating neurological "side- effects" from one dose of a new antibiotic, Floxin. His five-year probe of the entire legal drug culture raises frightening questions about legal drugs and the pharmaceutical industry, the single most profitable legal manufacturing industry in the world. This paperback edition contains a new afterword and expanded appendices highlighting specific ways to take drugs safely. Annotation c. Book News, Inc., Portland, OR (booknews.com)
Kirkus Reviews
A big, sprawling, highly personal inquiry into the making, approval, selling, and prescribing of drugs. When a single dose of the antiobiotic Floxin sent Diane Fried to the emergency room in delirium and left her with serious neurological problems, her journalist husband turned his investigative eye on Floxin's safety. It is a well-told story, fascinating and often frightening, occupying nearly a third of this book. From it, Fried (Thing of Beauty, 1993) then began a broader investigation into the pharmaceutical-industrial complex, seeking to find the flaws in the process by which drugs make it from pharmaceutical lab to family medicine cabinet. Fried attended medical and scientific conferences and government hearings, compiled enormous files of documents, and seemingly interviewed just about anyone with anything pertinent or interesting to tell him about the hazards of legal drugs: researchers, pharmaceutical company reps, FDA officials, and patients with adverse-reaction stories. Trying for the big picture, he seems more often to resemble the blind men struggling to figure out the nature of an elephant from its separate parts. While this work lacks focus, Fried has an ingratiating personal style and he provides some insightful interviews with insiders as well as information on the safety of quinolones (the drug family embracing Floxin), how the FDA dealt with thalidomide in the 1960s, the development of powerful protease inhibitors to treat AIDs, and the growth of direct-to-consumer marketing of prescription drugs. As might be expected, pharmaceutical companies come in for heavy criticism, but so does the federal government, for inadequacies in surveillance of drugs forpossible adverse affects once they're on the market. To reassure the nervous consumer, there's an appendix on how to read a drug package insert and how to ask the right questions of one's physician and pharmacist. For all its virtues, a collection of absorbing articles that never quite coalesces into a cohesive whole.
Read More Show Less

Product Details

  • ISBN-13: 9780553378528
  • Publisher: Random House Publishing Group
  • Publication date: 5/28/1999
  • Edition number: 1
  • Pages: 448
  • Sales rank: 988,529
  • Product dimensions: 6.13 (w) x 9.25 (h) x 0.88 (d)

Meet the Author

Stephen Fried is the author of three books, Thing of Beauty: The Tragedy of Supermodel Gia; Bitter Pills: Inside the Hazardous World of Legal Drugs; and The New Rabbi: A Congregation Searches for Its Leader. A two-time winner of the National Magazine Award, he has written articles for Glamour, Vanity Fair, GQ, and Rolling Stone. He is an adjunct professor at the Columbia University Graduate School of Journalism.

From the Hardcover edition.

Read More Show Less

Read an Excerpt

It began with a pill. One pill.

My wife's gynecologist gave her samples of a new antibiotic to treat a urinary tract infection so minor, she didn't even know she had it. The doctor told her to take this new wonder drug twice a day for three days.

Your doctor gives you a pill, you take it. When I left for work the next morning, I said good-bye to Diane as she swallowed the first pale yellow oval tablet with breakfast.

Six hours later I was bringing her, delirious, to the emergency room. Our lives haven't been the same since.

Diane called me at work several hours after she took that pill and said she felt strange. I knew something was really not right, because my wife comes from a long line of "it's just a flesh wound" stoics who underreact to all physical discomfort. She said she was disoriented and hallucinating. Her mouth was dry, and she felt tingling in her left arm and hand. She was having trouble talking.

After we spoke, she found herself wandering around in her small home office, and when she located her desk, she couldn't figure out how to turn off the computer she writes on every day. When she went to lie down, she started shaking uncontrollably and then saw white. She was sure she was dying.

Then she heard the phone ring. It was me, calling to see if she was feeling any better. Luckily, she was able to reach over, pick up the receiver and mumble to me about what was going on. I called her gynecologist, who told me to take her to the hospital. When the cab got me home from the office, I found Diane lost in her closet. She stammered that she wanted to get dressed to go out but couldn't find her white shirt. I looked down and saw that it was an inch from her hand.

Married people can afford to panic only one at a time, so I pretended I was not scared as I helped her on with the shirt and took her to the hospital closest to where we live in Philadelphia, which happens to be Pennsylvania Hospital, the oldest hospital in America and one of the very best. As Diane spoke--haltingly, elliptically--to the ER doctors, more symptoms emerged. Her jaw was terribly sore from clenching against what we assumed had been a seizure. Her pupils were fixed and dilated, like blobs of black ink. She said she felt as though something were "melting" just behind her green eyes.

It was late Friday afternoon at the ER, just before the weekend rush, so we got a good, slightly private, curtained-off area. An emergency medicine specialist and several neurology residents tag-teamed in and out of our space. Each one asked a slightly different version of the same questions. I worried that we weren't being clear because there didn't seem to be any accumulation of knowledge taking place. They all had tests they wanted Diane to perform.

"Spell the word "world' backwards," one asked. She did it and was then asked to name the U.S. presidents in reverse chronological order.

"Can you spell "world' backwards?" the next one asked. Then he requested that she touch her finger to her nose.

"I'd like you to try to spell--" the next one began.

"--yeah, yeah," Diane said, "'world' backwards." But she was bobbing in and out of full lucidity. Only seconds after cracking a joke, her mind would be sluggish again, and she would barely respond when I stroked her cheek or her shoulder-length brown hair.

After nearly five years of marriage, this was the first medical emergency we ever had to face. The only thing that kept me from really losing it was a woman in the next cubicle who already had lost it. Dragged in by the police in the middle of a major psychotic episode, she screamed continually in English and Chinese about everything from her husband's homosexuality to her close personal friendship with the president of the United States. Her screams pierced the crackly trauma calls from ambulances all over the area, which were being broadcast on a loudspeaker system for the ER staff to monitor. The combined noise was oddly stabilizing, a constant reminder that things could be considerably worse.

After several hours of neurological exams, the word came back--from a place called the Poison Control Center--that all of Diane's symptoms had been previously reported as reactions to the antibiotic she took. The drug is called Floxin. She had, as we now say, been "Floxed."

My wife took a pill. It made her sicker than she was before.

World backwards. Tell me about it.

The ER doctors, however, were not through with us. They still wanted to run more tests. Even though Diane's symptoms, such as "acute delirium," were consistent with a reaction to the Floxin, they could also be caused by a brain tumor, a stroke or a big horrible infection with larger neurological implications, like spinal meningitis. They wanted to do a CT scan.

I got to sit in the CT control room and watch the machinery visually slice and dice. There is nothing quite so frightening as watching your loved one's brain being scanned for tumors, especially when you're not exactly sure what a normal brain looks like. But it is also very moving to peer directly into your wife's mind. What spouse hasn't at one time or another wished to be able to do that?

Back in the ER after a clean scan, we were then told the prevailing wisdom about all adverse drug reactions: that the effects would subside when the medication left her system. And we were sent home--with a supply of the milder, cheaper antibiotic she probably should have taken in the first place for her urinary tract infection (UTI)--to wait for that to happen. On our way out, we walked past the main ER desk. On the wall behind it was a light box for reading X-rays, which was still illuminating pictures from the inside of Diane's brain. To the left of the viewer was a shiny metal towel dispenser. It was adorned with Floxin advertising magnets that had been left by some enterprising drug sales rep.

At that moment I thought the Floxinalia would actually make a nice detail for our emergency room horror story, the recitation of which would commence as soon as Diane was fine, ostensibly in a couple of days. But her symptoms did not disappear as promised. Some waned, but new ones developed. Besides the "melting" and the fixed pupils, she had really aggressive, buzzy insomnia, visual distortions that made the world seem six-dimensional and aphasia: she would get halfway through a sentence and just couldn't get the rest of the words out. For a woman with a high school trophy for "best negative debater" sitting on a shelf behind her desk, this was probably the scariest symptom of all.

Over the next two weeks, she endured an electroencephalogram (EEG), which tests electrical function in the brain; a magnetic resonance imaging (MRI) of her head, which offers more structural detail than the CT scan; and a spinal tap, to check the cerebrospinal fluid for infections, as well as some blood work. All these tests just to rule out any other possible explanation for her continuing symptoms than an adverse reaction to the drug--the same drug that was supposed to be long gone from her system. While the tests themselves were creepy, what they were testing for was absolutely horrifying. I found myself weighing which awful result would be most acceptable, watching the life we had planned to have pass before my eyes.

The tests all came back on a Thursday, one of the most harrowing days of our lives. As we were read the results over the phone by our internist, I found myself mentally checking off all the nightmares that had been eliminated by the process--"brain tumor, no; stroke, no; AIDS, no." But Diane still wasn't well. The doctors concluded that the drug reaction had triggered some genetic predisposition to neurological illness. Since her body hadn't been able to correct the situation naturally, she would need to take a combination of heavy-duty drugs, each with its own possible side effects, to do it. If, in fact, it could be done at all.

But at least that urinary tract infection had cleared up.

It has now been five years since Diane got Floxed. In that time, we have learned more than we thought we'd ever want to know about what has been called "the other drug problem." The one with legal drugs.

Since that day in the emergency room, I have been on a quest. An investigative journalist and exasperated husband, I am trying to find out if my wife was the victim of a pharmacological foul-up or just a statistically acceptable casualty of "friendly fire" in the war on disease. I am also trying to find meaning in our experience, a married couple searching for each other through a medical emergency that never seems to end, the siren never completely quieted.

Along the way, I have met the people behind the studies, the statistics, the press releases and the lawsuits: heroes, scoundrels, geniuses and idiots, victims and victimizers, the amorphous "less than one percent" of the population who have the adverse reactions you read about in the fine print on your drug labels and even the people who massage the numbers to get them under one percent. I have seen close up what happens at that moment when science officially becomes commerce, when exciting new drugs are handed over from the lab nerds to the marketing types. I have watched everyone in the pharmaceutical food chain describe everyone but themselves as unhealthily arrogant. I have seen the world's top drug cop, the head of the U.S. Food and Drug Administration (FDA), excoriated as a "thug," a "bully" and even a "killer" by an industry-friendly legislator. And I have listened to the head of one of America's largest drugstore chains turn to me and growl, "These drug companies always hide under the cloak of "We're these great research and development houses and without us there would be no medications.' I think they're full of shit."

The Europeans have a very elegant word for a certain type of drug safety research. The word is pharmacovigilance, and it refers to research that is supposed to be done after a drug has been approved and we're taking it. Because the people who do this work are the sole link between the pharmaceutical world and the real world and are often the bearers of unwelcome news, they sometimes seem like pharmacovigilantes. Over these years, I have been doing my own form of pharmacovigilantism. I use my press credentials to move effortlessly between the camps warring for control of your medicine cabinet.

My quest began with tracking down everything I could find about Floxin. But I realized that the only way to understand what had happened to Diane was to see beyond one pill and journey to the heart of the legal-drug culture: the international pharmaceutical industry, the government drug police in countries large and small, the physicians, the researchers, the pharmacists, the nurses, the consumer advocates--and the patients who unwittingly place their blind faith in this system. In college there was a book we had to read for political science class called The Dance of Legislation, about how a bill becomes law. Since Diane's drug reaction, I have been investigating politicized science and watching "the dance of medication"--how a pill becomes law.

Much to my surprise, I found that the world of legal drugs is actually far more fascinating than its illicit counterpart, where we journalists generally focus our attention. It can also be more dangerous. While pharmaceutical science has made some medical miracles almost routine, the sheer size of the legal-drug world means that its problem areas are bigger than the entire illegal-drug problem.

For example, far more people die each year from adverse reactions to prescription and over-the-counter medications than succumb to all illegal drug use. Illicit drugs kill anywhere from 5,000 to 10,000 Americans a year. The estimates for U.S. deaths from legal drugs have ranged from 45,000 to over 200,000 per year, which represents 2 to 9 percent of the 2.3 million people who die annually, thereby qualifying as at least the sixth leading cause of death in America, and possibly as high as the third--behind only heart disease and cancer. Of course, many people take many medications without experiencing such problems, which are referred to as "adverse drug reactions" in the United States, "medication misadventures" in the U.K. and "drug-induced sufferings" in Japan. But according to studies in the Journal of the American Medical Association (JAMA), as many as 11 percent of all hospital admissions are the result of adverse drug reactions, or ADRs, as they are often called. More than one-quarter of all inpatients have adverse reactions to the drugs they are given in the hospital--many the result of preventable medication errors--which makes ADRs the leading cause of in-hospital injury.

In America more people die each year from reactions to the drugs they get in the hospital than are killed in automobile accidents. (Some 10 percent of all auto accidents involve drivers impaired by medications.) Outpatients are victimized in greater numbers in another way by drug reactions: they stop taking their pills after being spooked by annoying side effects, neglect to tell their doctors, and are then hurt or killed by the untreated illness.

Before Diane got Floxed, I thought of medicines as pretty much idiot-proof. You take them assuming that the worst that can happen is that they won't work. It turns out the worst that can happen is that you drop dead. The next worse is that your body is permanently damaged. Less worse, but still not very good, is that you suffer for hours, days or weeks with something your doctor may or may not recognize as a drug reaction--anything from a skin rash to heart failure to a sudden inability to have an orgasm. The symptom may or may not go away by itself, but until it does, your doctor may mistake it for another illness and give you more drugs for that, leading to a cascade of prescribing. And your drug experience may affect how the next medication you take works in your body--or how well your body is able to fight infection in the future.

Adverse drug reactions are clearly a huge international health problem. A few enlightened pharmacologists also see them as an enormous learning opportunity, a "gift" that accidentally offers a chance to deepen understanding of drugs and the human body. For me, they have been both. Understanding drug reactions has been a way to explore what is wrong with the entire international pharmaceutical business--a $250 billion enterprise ($700 billion if you count all the other products sold by drug companies) that has managed to repel scrutiny more effectively than almost any other major industry, while remaining the world's most profitable business through many changes in economic climate.

Asking questions about what government regulators were doing about the drug reaction problem also became my way of infiltrating the FDA, an agency so misunderstood that it is easy to overlook its omnipresence in our lives. The FDA is responsible for regulating 25 percent of America's entire gross national product and its policies are the benchmark for world regulation of drugs and medical devices.

The work done by understaffed national agencies like the FDA has never been more important, because in all too many cases, the new economics of health care have transformed drugs from one possible treatment into the only possible treatment--or at least the only reimbursable treatment. In the past five years, drug sales in U.S. pharmacies and outpatient clinics have risen more than 50 percent and the total number of prescriptions dispensed, more than 2 billion a year, has risen over 25 percent. The vast majority of those increases are attributable to managed care's growing use of drugs to avoid hospitalization.

Drugs have become not only the tail that wags the dog but the tail that feeds the dog, trains the dog and makes the dog do tricks. And the growing power of the pharmaceutical industry is being controlled by a shrinking base of owners. Not only are the huge "drug houses" merging with each other and streamlining, but they are buying the firms that decide which drugs will be made available to patients in HMOs and other managed health care organizations. The companies also control the flow of information about medicines. The drug industry now funds, directly or indirectly, almost all the research done on drug products and almost all the drug education doctors get after medical school. Most of the destigmatizing public-awareness advertising campaigns about illnesses are paid for by the companies whose drugs are used to treat or in some cases define those illnesses. And more than ever, drug companies are end-running physicians' authority by advertising directly to consumers, which is why your magazines and n ewspapers are overflowing with pharmaceutical ads, your favorite TV shows are interrupted by pleas to "ask your doctor" about drugs and your doctor is quietly wincing every time he or she is "asked."

It's a situation that can easily turn unhealthy and too often does. Companies can't always be counted on to do "the right thing" when they're faced with a tough choice between profit and public safety. Experts in the field are growing worried about where the in-house "conscience" of these companies will be found, especially when firms with sterling reputations merge with their less high-minded competitors.

While drug therapies grow stronger and more profitable every day, the system that is supposed to assure the safety of those drugs is getting relatively weaker, an economic and bureaucratic liability easily targeted for downsizing. Even as computers and easier international communication make more drug safety efforts possible, the chasm between what can be done and what is being done to keep us safe grows constantly larger.

Ten years ago, the bottom-line business practices of the pharmaceutical companies were considered by many to be the dark underside of health care. Today, all of health care is being run like a drug company.

It's no wonder that, more than ever, patients and their doctors feel--well, pillaged.

Read More Show Less

Table of Contents

Prologue 1
PART I
CHAPTER 1 All Floxed Up 13
CHAPTER 2 Less Than One Percent 33
CHAPTER 3 MedWatchers 56
CHAPTER 4 "Nobody Reads the Label Anyway" 80
CHAPTER 5 The Ray and Dave Show 97
CHAPTER 6 Pharm TV 109
PART II
CHAPTER 7 Nit-picking 125
CHAPTER 8 The Summer of Drugs 140
CHAPTER 9 Psychopharm 151
CHAPTER 10 The Temafloxacin Syndrome 170
CHAPTER 11 Table 7 184
CHAPTER 12 "What If Things Go South?" 193
CHAPTER 13 Generation Rx 208
PART III
CHAPTER 14 Detail Men 223
CHAPTER 15 Countries unto Themselves 242
CHAPTER 16 Nice to Know 260
CHAPTER 17 Facing Up to Retin-A 281
CHAPTER 18 Self-Medication 294
CHAPTER 19 Spin Control 309
CHAPTER 20 Attack of the Killer Formularies 329
CHAPTER 21 The Race to the Cocktail 346
CHAPTER 22 Checkered Flag 363
Epilogue 376
Appendix Bitter Pills: The Antidotes 382
How to Read a Drug Package Insert 383
How to Make Your Doctor Write Smart Prescriptions 389
How to Avoid Adverse Drug Reactions 393
International Guide to Drug Information on the World Wide Web 395
Medication Diary 402
Acknowledgments 403
Selected Bibliography 407
Index 411
Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)